公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2017 | Checkpoint Inhibitors in Metastatic EGFR-Mutated Non-Small Cell Lung Cancer-A Meta-Analysis | Lee C.K; Man J; Lord S; Links M; Gebski V; Mok T; CHIH-HSIN YANG | Journal of Thoracic Oncology | 637 | ||
2018 | Clinical and molecular characteristics associated with survival among patients treated with checkpoint inhibitors for advanced non-small cell lung carcinoma: A systematic review and meta-analysis | Lee C.K; Man J; Lord S; Cooper W; Links M; Gebski V; Herbst R.S; Gralla R.J; Mok T; CHIH-HSIN YANG | JAMA Oncology | 430 | 281 | |
2019 | Predictive value of PD-L1 and other clinical factors for chemoimmunotherapy in advanced non-small-cell lung cancer | Woodford R; Loh Y; Lee J; Cooper W; Marschner I; Lewis C.R; Millward M; Lord S; Gralla R.J; CHIH-HSIN YANG ; Mok T; Lee C.K. | Future Oncology | 4 | 4 | |
2018 | The Value of Early Depth of Response in Predicting Long-Term Outcome in EGFR-Mutant Lung Cancer | Lee C.K; Lord S; Marschner I; Wu Y.L; Sequist L; Rosell R; Fukuoka M; Mitsudomi T; Asher R; Davies L; Gebski V; Gralla R; Mok T; Chih-Hsin CHIH-HSIN YANG | Journal of Thoracic Oncology | 14 | 17 |